Glaxosmithkline Pharmaceuticals Limited
Get the Full Report for Glaxosmithkline Pharmaceuticals Limited
See every shipment, partner, and contact.
Contact Glaxosmithkline Pharmaceuticals Limited
Reach the right decision-maker by email or phone.
Grab Limited-Time Offer
7-day free trial. No credit card needed.
| HS Code | Description | USD Value | Shipments | Share |
|---|---|---|---|---|
| 30049087 | MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | $70.0K | 2 | 0.05% |
| 84713010 | AUTOMATIC DATA PROCESSING MACHINES AND UNITS THEREOF; MAGNETIC OR OPTICAL READERS, MACHINES FOR TRANSCRIBING DATA ON TO DATA MEDIA IN CODED FORM AND MACHINES FOR PROCESSING SUCH DATA, NOT ELSEWHERE SPECIFIED OR INCLUDED | $70.0K | 1 | 0.02% |
| 90181990 | INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES, INCLUDING SCIENTIGRAPHIC APPARATUS, OTHER ELECTROMEDICAL APPARATUS AND SIGHT-TESTING INSTRUMENTS | $70.0K | 3 | 0.07% |
| 30029090 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $40.0K | 3,911 | 90.97% |
| 30029010 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $0 | 363 | 8.44% |
| HS Code | Description | USD Value | Shipments | Share |
|---|---|---|---|---|
| 30024119 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $25.77M | 53 | 8.24% |
| 30024129 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $15.26M | 26 | 4.04% |
| 29419090 | ANTIBIOTICS | $5.30M | 70 | 10.89% |
| 30024121 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $4.15M | 11 | 1.71% |
| 30024112 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | $3.49M | 7 | 1.09% |
| Country | USD Value | Shipments | Share |
|---|---|---|---|
| Germany | $140.0K | 7 | 0.16% |
| Indonesia | $70.0K | 2 | 0.05% |
| Singapore | $40.0K | 3,709 | 86.28% |
| United Kingdom | $0 | 549 | 12.77% |
| Belgium | $0 | 9 | 0.21% |
| Country | USD Value | Shipments | Share |
|---|---|---|---|
| Belgium | $36.82M | 79 | 12.29% |
| Germany | $11.27M | 97 | 15.09% |
| Italy | $5.82M | 28 | 4.35% |
| Hungary | $4.07M | 34 | 5.29% |
| China | $2.74M | 91 | 14.15% |
| Port | USD Value | Shipments | Share |
|---|---|---|---|
| Bombay Air Cargo | $230.0K | 2,810 | 65.36% |
| Delhi Air Cargo | $20.0K | 1,467 | 34.12% |
| Chennai Air Cargo | $0 | 21 | 0.49% |
| Ahmedabad Air Cargo | $0 | 1 | 0.02% |
| Port | USD Value | Shipments | Share |
|---|---|---|---|
| Bombay Air Cargo | $54.14M | 480 | 74.65% |
| Nhava Sheva Sea | $13.04M | 160 | 24.88% |
| Bangalore Air Cargo | $40.0K | 2 | 0.31% |
| Zydus Infrastructure Pvt. Ltd. (sez) | $0 | 1 | 0.16% |
- Glaxosmithkline Pharmaceuticals Limited mostly sells to other countries. They sent 3,287 exports and got 545 imports.
- Their main product is medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed … (
HS 30049087). It is 0.05% of all trade.
Glaxosmithkline Pharmaceuticals Limited is an exporter from Germany. We have 3,832 shipment records for them. They have 545 imports from 39 suppliers, and 3,287 exports to 28 buyers.
Most of their exports go to Germany. This is their main market.
This page shows trade records for Glaxosmithkline Pharmaceuticals Limited. The data comes from public customs and port records. to see all shipments, decision-maker contacts, and trade alerts.
How many shipments does Glaxosmithkline Pharmaceuticals Limited have on record?
Glaxosmithkline Pharmaceuticals Limited has 545 import shipments and 3,287 export shipments on record based on public customs filings indexed by ShipScout.
Where is Glaxosmithkline Pharmaceuticals Limited based?
Customs records indicate Glaxosmithkline Pharmaceuticals Limited primarily operates from Germany.
Who are Glaxosmithkline Pharmaceuticals Limited's top buyers?
Glaxosmithkline Pharmaceuticals Limited's top buyers include OOO Jodas Expoim, DR Reddys Laboratories INC, Agio RUS LLC. The full buyer list is available on ShipScout.
What products does Glaxosmithkline Pharmaceuticals Limited trade?
Glaxosmithkline Pharmaceuticals Limited's top exported HS codes include HS 30049087, HS 84713010, HS 90181990.
How can I get full shipment history for Glaxosmithkline Pharmaceuticals Limited?
Request access to view the complete shipment history, contact intelligence and trade partners for Glaxosmithkline Pharmaceuticals Limited on ShipScout.
Browse by Product Code
Get the Full Report for Glaxosmithkline Pharmaceuticals Limited
See every shipment, partner, and contact.
Contact Glaxosmithkline Pharmaceuticals Limited
Reach the right decision-maker by email or phone.
Grab Limited-Time Offer
7-day free trial. No credit card needed.